chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itching; red rash; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (itching) and RASH ERYTHEMATOUS (red rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 11-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching) and RASH ERYTHEMATOUS (red rash). At the time of the report, PRURITUS (itching) and RASH ERYTHEMATOUS (red rash) outcome was unknown.            no concomitant drugs included no treatment drugs included
Suspected vaccination failure; shingles / expecting it to be mild. If this is mild I do not want to see the real strength; nothing I can compare it with. Plain awful; This case was reported by a consumer via media and described the occurrence of vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient.  The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication.   Three years before the date of reporting, the patient received Shingles vaccine and now experienced shingles. The patient was expecting it to be mild and if this was mild do not want to see the real strength. The patient reported there was nothing can compare it with, plain awful. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule and laboratory test confirmation for shingles infection were unknown. Note: event pain was captured in the case because it seem that there is typo error because it was reported as plain awful instaed of pain awful.
Having runny yellow diarrhea stools every 3-4 hrs.  No vomiting.  No fever.  No URI symptoms.  Some decreased appetite X2d.  Tried pedialyte:  diarrhea continued currently on Augmentin and Ancid for GERD.
I contracted COVID-19 on 06/18/2022 with symptoms of severe swollen glands, cough, weakness, fatigue, and temperature fluctuations dropping below 95 degrees and up to 97.3 while my normal temperature is 97.5 due to fibromyalgia. I was not prescribed any medication over my telemedicine visit. I was ill for over 14 days before my symptoms began to improve. I am still experiencing lingering symptoms of fatigue and the temperature fluctuations. I have been sleeping between 12 and 14 hours a night and still wake up fatigued.
tested positive for Covid; tested positive for Covid; This is a spontaneous report received from a non-contactable consumer (patient) reporting for himself. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER COVID-19 VACCINE, lot no. and expiry date were not reported), via an unspecified route of administration on unspecified date in 2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first vaccine on the 14th (complete date not reported) and tested positive for Covid with a rapid results test (unspecified date in 2021). The patient wants to know about getting second shot. The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
COVID breakthrough; COVID breakthrough; headache; This is a spontaneous report from a contactable consumer. A 45-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) at age of 44-years-old as DOSE 2, SINGLE; dose 1 via an unspecified route of administration on Feb2021 (Batch/Lot number was not reported) at age of 44-years-old as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced COVID breakthrough-fevers, chills, headache, loss of smell and taste on 03Nov2021 with outcome of not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included COVID test: Positive on 03Nov2021.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Arm red and swollen from shoulder to elbow. Has not treated, will begin to put cold wash clothes on arm 3x day and give Tylenol.
Anaphylaxis. Acute drop in blood pressure - 88/58. Sweating, weakness, ringing in ears.
Around 3 pm today, my left arm itched. I scratched it a bit thinking nothing of it. Around 1 hr later I saw my arm in the mirror and there is a red rash.
2 days after getting the vaccines in his thighs- a rash developed on his thighs- the next day the rash spread down his entire legs on both sides- the following day the rash gets better.
A spontaneous report has been received from a Health Professional concerning a patient of unknown gender. No information regarding relevant medical history, concomitant disease or concomitant medication was provided. The patient was prescribed Nasal FLUENZ (intranasal) started on unknown date. The reporter stated that the patient experienced incorrect administration of FLUMIST- entire dose of administered into single nostril. The outcome of the event of incorrect administration of FLUMIST-entire dose administration into single nostril was unknown. The reporter considered the event of incorrect administration of FLUMIST- entire dose administered into single nostril as non-serious. The reporter and company considered the event of incorrect administration of FLUMIST-entire dose administered into single nostril with FLUENZ to be related.
Deltoid area site of Dtap vaccine, slightly swollen, mild erythema, client afebrile today. Area not hot to touch N/C of pain upon palpation. Advised mother if client complains of pain if condition worsened seek advise of PCP.
Patient received both doses of the Pfizer vaccine on 2/24/21 and 3/17/21. Patient came to the ER on 5/8/21 with chest pain, where she tested positive for COVID. While patient was receiving a precordial drain she went into V. tach but was successfully resuscitated. She went to ICU but went into cardiopulmonary arrest and died on 5/9/21.
Narrative:  COVID infection following COVID vaccine series 05/21 Janssen, dose #1 08/11 COVID swab, result: detected 08/11 pt admit to OBS DX: Syncope w collapse ro TIA ** pt AMA an COVID19 illness without hypoxia 08/14 pt cc: exposure: unknown clinically resolved
Face flushed/warm & injection site warm & blotchy within 5 minutes of injection.  Gave Benadryl 25 mg at 1350 po & 40 minutes of ice to site.
small blotchy rash below injection site presenting a week later; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (small blotchy rash below injection site presenting a week later) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (small blotchy rash below injection site presenting a week later). At the time of the report, VACCINATION SITE RASH (small blotchy rash below injection site presenting a week later) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported No treatment was reported.   Reporter did not allow further contact
LOST APPETITE; STOMACH HURTS; SHORTNESS OF BREATH; HEADACHE; NAUSEA; FATIGUE /  VERY TIRED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and abstains from alcohol, and other pre-existing medical conditions included patient had no known drug allergies. patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose was not reported, administered on 18-MAR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported and has been requested. On 20-MAR-2021, the subject experienced lost appetite. On 20-MAR-2021, the subject experienced stomach hurts. On 20-MAR-2021, the subject experienced shortness of breath. On 20-MAR-2021, the subject experienced headache. On 20-MAR-2021, the subject experienced nausea. On 20-MAR-2021, the subject experienced fatigue. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 23-MAR-2021, and had not recovered from lost appetite, nausea, stomach hurts, fatigue, and shortness of breath. This report was non-serious.
Pt took her 2nd dose pfizer covid-19 vaccine at a medical facility on 5/26/21. Pt said, she didn't feel symptoms until she woke up today. Per pt, she has Palpitations when at rest and worse when she walks, headache, stomach ache, and back ache.
The morning after getting this flu shot I suddenly came down with fever, chills, muscle aches, fatigue, muscle weakness, and sore throat.  It feels exactly like I have the full-blown flu.  I went to work in the early morning and had to leave at 11 because I couldn't keep my head up anymore.
headache, cough, fever, chills, body aches, shortness of breath, eyes are burning starting 12/10/21
Headaches about 3 days after the shot that lasted 5 days.  Then about a two weeks after the vaccination, headaches and dizziness along with puffiness in the left eye and mild fatigue have been continuously happening for two weeks straight.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On 01-DEC-2016, the patients were vaccinated with improperly stored doses of ZOSTAVAX injection, subcutaneously, lot # M032360, expiration date: 18-AUG-2017 (exact dose and anatomical location were not provided). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 32.54 degrees Fahrenheit for 4.5 hours. Data logger was involved. There were no previous excursions reported. Additional information has been requested.
Wrist is stiff; Minor itch on upper neck and front part of abdomen; Localized rash to her upper neck and front part of abdomen; Swelling to the point of feeling it was arthritic pain all way down to the fingertips; Feeling like arthritic pain; Sore at the injection site; Sore from injection site to the fingertips; A spontaneous report was received from a consumer concerning a female patient of an unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore at the injection site, sore from injection site to the fingertips, swelling to the point of feeling it was arthritic pain all way down to the fingertips, feeling like arthritic pain, wrist is stiff, localized rash to her upper neck and front part of abdomen and minor itch on upper neck and front part of abdomen.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 30 Dec 2020 the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) via unknown route for prophylaxis of COVID-19 infection.   A consumer called to report she had received the Moderna's  COVID-19 vaccine on 30 Dec 2020 at 2:45pm. Later than evening, 7 hours post injection, was sore at the injection site to the point it "woke me up". The next morning, she stated she was sore from the injection site to the fingertips, sore and swelling to the point of feeling it was arthritic pain all the way down to her fingertips, currently feeling that way. Wrist is stiff, cannot take lid off. On Friday morning she stated she had a localized rash to her upper neck and front part of abdomen, it did itch (minor itch), similar to a sunburn type of reaction. It resolved after taking Claritin D.   Treatment for the event Localized rash to her upper neck and front part of abdomen and Minor itch on upper neck and front part of abdomen included Claritin D.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, Sore at the injection site, Sore from injection site to the fingertips, swelling to the point of feeling it was arthritic pain all way down to the fingertips, Feeling like arthritic pain and Wrist is stiff were considered unknown. The outcome of the events, Localized rash to her upper neck and front part of abdomen and Minor itch on upper neck and front part of abdomen, were considered as recovered/resolved.; Reporter's Comments: Based on the information provided which includes a strong temporal association between the reported events and administration of mRNA-1273 vaccine, an excluding any other etiology, a causal association cannot be excluded. Vaccination site pain, injection site swelling, rash and arthralgia are consistent with the known safety profile of the vaccine.
Red rash on arm where shot administered, warm to the touch. Recommend tx: cold compress, anti-inflammatory or antihistamine.
2 days after shot - muscle soreness, then 1 week after pain up side arm and from neck to ear with normal activities. Pain feels like pins and needles.
was unable to raise my arm; itchiness; injection site swelling; This spontaneous case was reported by a pharmacist and describes the occurrence of LIMB DISCOMFORT (was unable to raise my arm), PRURITUS (itchiness) and VACCINATION SITE SWELLING (injection site swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 042L20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D3 and VITAMIN B12 NOS for an unknown indication.   On 09-Jan-2021 at 7:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE SWELLING (injection site swelling). On an unknown date, the patient experienced LIMB DISCOMFORT (was unable to raise my arm) and PRURITUS (itchiness). On 20-Feb-2021, VACCINATION SITE SWELLING (injection site swelling) had resolved. At the time of the report, LIMB DISCOMFORT (was unable to raise my arm) and PRURITUS (itchiness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-027305 (Patient Link).
tested positive to Covid. Rapid Test used; tested positive to Covid. Rapid Test used; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Mar2021 as dose 1, single (Lot number: ER2613), in right arm, on 08Apr2021 as dose 2, single (Lot number: ER829), in right arm and on 20Nov2021 as dose 3 (booster), single (Lot number: FJ1620) at the age of 47 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Lidocaine, reaction(s): "Known allergies: Lidocaine". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 01Aug2022, outcome "not recovered" and all described as "tested positive to Covid. Rapid Test used". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Aug2022) positive, notes: tested positive to COVID. Rapid Test used. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Clinical course: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient did not diagnosed with COVID-19. Other medical history: No.  No follow-up attempts are possible. No further information is expected.
After receiving the vaccine I notice when I woke up at night or in the morning my right hand only felt like it was asleep. Was not concerned since I have a fatty tumor in that arm and thought it was what was causing it.  Now about a week ago that has stopped but my left foot now has the same symptoms.  It happens mostly at night but also happens occasionally during the day.  It feel like its asleep and numb.  Now I am wondering if its not the vaccine since this has never happened before.
7/24/19: Pain at injection site.    7/25/19 Chills, body aches, head ache, nausea, vomiting, low grade fever (100), pain at injection site. 7/26/19 Head ache, body aches (especially backache), weakness, dizziness, nausea, pain at injection site. 7/27/10 Weakness, intermittent dizziness and nausea, eye pain, difficulty talking due to weakness, intermittent fever-like symptoms (chills, aches) 7/28/19 Weakness, tiredness, dizziness. Diarrhea Eye pain 7/29/19  Weakness, eye  pain, diarrhea, dizziness 7/30/19 Weakness, tired, eye pain, diarrhea,  dizziness
ran a little fever/ hot and cold; get tired very easily; headache; Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (ran a little fever/ hot and cold), FATIGUE (get tired very easily), HEADACHE (headache) and MYALGIA (Myalgia) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cardiac function test on 09-Mar-2021. Concomitant products included MACROGOL 3350 (MIRALAX) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (ran a little fever/ hot and cold), FATIGUE (get tired very easily), HEADACHE (headache) and MYALGIA (Myalgia). At the time of the report, PYREXIA (ran a little fever/ hot and cold), FATIGUE (get tired very easily), HEADACHE (headache) and MYALGIA (Myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated she took vaccine at  Hospital in  and tomorrow she has to undergo ECHO, worried a much. Patient is taking vitamins for eye but unknown. No treatment information provided.
10/15/14 - received dose. 10/24/14 - admitted hospital - pneumonia, seizures, stroke. 10/29/14 - discharged - diagnosed stroke, AFib, pneumonia. 12/23/14 - admitted - syncope, seizures, stroke. Presently hospital.
Achy, sore and radiating pain in arm. Shivering and shakes. She felt like she had a fever, but did not take her temp. Currently no fever. Had blotchy area around injection site. She also developed some nausea - upset stomach. She described the pain as severe. Felt horrible. Improving now. Blotchy area like a rash.
Bells Palsy and treating  him with prednisone 60 mg for 1 week
Fever, chills, nausea, excessive vomiting, lower back aches, body aches, headache, exhaustion, dizziness, diarrhea, sensitivity to light, etc.
Presented to the emergency department on 2/28/21 with exertional shortness of breath and upper abdominal discomfort for the past 2 days. Patient was admitted to the hospital, and pulmonary edema was contributed to right-sided heart failure from his mild COPD and suspected underlying interstitial lung disease. Per the EUA, hospitalizations are to be reported irrespective of attribution to vaccine. This hospitalization does not appear to be related to the vaccine.
Left upper arm (shoulder to elbow) with large amount of erythema and swelling (arm twice the size of right arm). Was very warm and tender to the touch. Pt complains of itching at the area. Pt taking Tylenol and using ice for pain/swelling.
I COULD NOT GET AND KEEP MY BALANCE.  I FELT LIKE I WAS REALLY DRUNK.  I WAS TAKEN TO ARH BY AMBULANCE.
Baby Covid Bivalent dose was given. She needed the Pediatric Bivalent dose. Patient did not have an adverse reaction.
11/22 mid day I began having cough, runny nose, headache fatigue. 11/23 symptoms stayed consistent but tested that evening to see if it was COVID-19 and I was positive. 11/26 I was able to reach the on call physician and was prescribed PAXLOVID and began taking it that evening. Symptoms didn't seem to begin improving until today 11/30 and I am beginning to feel better.
Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: swelling of the lips, and numbness/tingling of the left side of the face
Full body rash. Started 4 days after 2nd shot. Still have rash as of today, 7th day after shot; This is a spontaneous report from a contactable consumer.   A 63-year-old-male consumer (patient) reported for himself. A 63-years-old male patient received second dose of BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, formulation: solution for injection, Batch/lot number: EW0182) via unknown route of administration in right arm on 12May2021 at 9:30 (at the age of 63 years old) as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history included Being treated for rectal cancer, allergy to Neosporin and Systemic sclerosis on 19Nov2020. Concomitant medication included loperamide hydrochloride (IMODIUM AD) for an unknown indication from an unknown date. Historical vaccine included first dose of BNT162B2 (Pfizer-BioNTech Covid-19 Vaccine, formulation: solution for injection, Batch/lot number: ER8731) via unknown route of administration in left arm on 21Apr2021 at 09:45AM (at the age of 63 years old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16May2021, the patient experienced full body rash, started 4 days after 2nd shot. Still had rash as of today, 7th day after shot. the patient was not diagnosed with COVID-19, Prior to vaccination and not tested for COVID-19, Since the vaccination. The patient did not receive treatment for the event. At the time of this report the outcome of the event was not recovered.  No follow-up attempts were needed. No further information was expected.